Jabodon PT Co’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,981,258
Closed -$751K 4
2024
Q1
$751K Hold
3,981,258
0.53% 3
2023
Q4
$647K Hold
3,981,258
0.5% 3
2023
Q3
$1.76M Hold
3,981,258
2.83% 2
2023
Q2
$1.47M Sell
3,981,258
-591,580
-13% -$505K 1.97% 3
2023
Q1
$8.32M Hold
4,572,838
10.88% 3
2022
Q4
$9.47M Hold
4,572,838
12.83% 3
2022
Q3
$13.8M Hold
4,572,838
18.56% 2
2022
Q2
$14.6M Hold
4,572,838
20.3% 2
2022
Q1
$29.5M Sell
4,572,838
-447,357
-9% -$4.05M 13.39% 2
2021
Q4
$67.3M Hold
5,020,195
30.74% 1
2021
Q3
$59.3M Buy
+5,020,195
New +$79.1M 24.56% 1

Other funds holding HLTH

Jabodon PT Co's HLTH Position: Q2 2024 in Review

Jabodon PT Co sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 3,981,258 shares — an estimated $751K sold.

Jabodon PT Co first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $67.3M in Q4 2021. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Jabodon PT Co reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jabodon PT Co sold 3,981,258 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $751K.
  • Jabodon PT Co first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Jabodon PT Co's Cue Health Inc. Common Stock position peaked at $67.3M in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Jabodon PT Co's 13F filing for Q2 2024, filed 19 Jul 2024.